ストックスクリーナーアプリを入手
30.96
1.31%
-0.41
アフターアワーズ：
30.96
前日終値:
$31.37
開ける：
$31.41
24時間の取引高:
301.56K
Relative Volume:
1.13
時価総額：
$1.30B
収益：
$384.90M
当期純損益:
$-851.00K
株価収益率:
-1,548.00
EPS:
-0.02
ネットキャッシュフロー:
$12.83M
1週間 パフォーマンス:
+0.98%
1か月 パフォーマンス:
+8.29%
6か月 パフォーマンス:
+14.03%
1年 パフォーマンス:
+85.17%
1日の値動き範囲:
$30.62
$31.63
1週間の範囲:
$30.11
$32.18
52週間の値動き範囲:
$16.48
$32.33
Artivion Inc Stock (AORT) Company Profile
AORT を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
AORT
Artivion Inc
|
30.96 | 1.30B | 384.90M | -851.00K | 12.83M | -0.02 |
|
ABT
Abbott Laboratories
|
127.93 | 221.89B | 41.95B | 13.40B | 6.49B | 7.65 |
|
BSX
Boston Scientific Corp
|
102.36 | 150.86B | 15.91B | 1.79B | 1.89B | 1.21 |
|
SYK
Stryker Corp
|
391.29 | 149.17B | 22.60B | 2.99B | 3.49B | 7.76 |
|
MDT
Medtronic Plc
|
90.82 | 116.46B | 33.00B | 4.29B | 5.50B | 3.27 |
|
EW
Edwards Lifesciences Corp
|
72.45 | 42.73B | 6.60B | 4.16B | 490.10M | 6.93 |
Artivion Inc Stock (AORT) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-10-23 | 開始されました | JMP Securities | Mkt Outperform |
| 2022-09-27 | 繰り返されました | Lake Street | Buy |
| 2022-08-08 | 開始されました | Lake Street | Buy |
| 2022-03-03 | 開始されました | Stifel | Buy |
Artivion Inc (AORT) 最新ニュース
Artivion (NYSE:AORT) Receives Buy Rating from Needham & Company LLC - MarketBeat
Needham & Company LLC Reiterates Buy Rating for Artivion (NYSE:AORT) - Defense World
Where Artivion Stands With Analysts - Benzinga
Oppenheimer maintains Artivion Outperform with $32 target - MSN
Oppenheimer maintains Artivion stock with $32 target By Investing.com - Investing.com Canada
Oppenheimer maintains Artivion stock with $32 target - Investing.com
Artivion Announces Presentation of Late-Breaking Data from AMDS PERSEVERE Trial at the 61st Society of Thoracic Surgery Annual Meeting - PR Newswire
Artivion, Inc. (NYSE:AORT) Holdings Raised by JPMorgan Chase & Co. - MarketBeat
JPMorgan Chase & Co. Has $2.61 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Is Artivion, Inc. (AORT) Among Billionaire Joseph Edelman’s Long-Term Stock Picks? - MSN
Artivion (NYSE:AORT) Hits New 1-Year HighTime to Buy? - MarketBeat
CryoLife Stock Soars to 52-Week High, Hits $30.62 By Investing.com - Investing.com Australia
CryoLife Stock Soars to 52-Week High, Hits $30.62 - Investing.com
GAMMA Investing LLC Purchases 497 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Why Investors Shouldn't Be Surprised By Artivion, Inc.'s (NYSE:AORT) P/S - Simply Wall St
New Strong Buy Stocks for January 7th - MSN
Artivion, Inc. (NYSE:AORT) Shares Sold by Principal Financial Group Inc. - Defense World
Franklin Resources Inc. Boosts Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Geode Capital Management LLC Has $23.46 Million Stock Position in Artivion, Inc. (NYSE:AORT) - Defense World
Jane Street Group LLC Has $1.63 Million Stock Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Barclays PLC Purchases 54,996 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Barclays PLC Has $1.89 Million Stock Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Jane Street Group LLC Purchases 24,945 Shares of Artivion, Inc. (NYSE:AORT) - Defense World
Artivion: Current Valuation Seems Stretched (NYSE:AORT) - Seeking Alpha
Lord Abbett & CO. LLC Invests $5.80 Million in Artivion, Inc. (NYSE:AORT) - MarketBeat
The Manufacturers Life Insurance Company Has $522,000 Stake in Artivion, Inc. (NYSE:AORT) - Defense World
Fmr LLC Has $3.07 Million Holdings in Artivion, Inc. (NYSE:AORT) - Defense World
Fmr LLC Buys 25,176 Shares of Artivion, Inc. (NYSE:AORT) - MarketBeat
Tidal Investments LLC Has $4.18 Million Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
Wellington Management Group LLP Boosts Holdings in Artivion, Inc. (NYSE:AORT) - MarketBeat
BNP Paribas Financial Markets Boosts Stock Position in Artivion, Inc. (NYSE:AORT) - MarketBeat
Artivion (NYSE:AORT) Earns “Market Outperform” Rating from JMP Securities - Defense World
Artivion says cybersecurity incident has disrupted order, shipping processes - MedTech Dive
Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2024 Financial Results - Kilgore News Herald
In-Depth Examination Of 6 Analyst Recommendations For Artivion - Benzinga
Ransomware disrupts Artivion’s shipping processes - SC Media
Artivion's chief accounting officer Amy Horton sells shares for $128,398 By Investing.com - Investing.com South Africa
Artivion, Inc. Grants FDA Humanitarian Device Exemption for the AMDS Hybrid Prosthesis - Marketscreener.com
Top US heart surgery device maker hit by ransomware attack - TechRadar
Artivion’s (AORT) “Buy” Rating Reaffirmed at Needham & Company LLC - Defense World
Artivion Cyberattack: Systems Offline, Operations Continue - The Cyber Express
Artivion reports cybersecurity incident, expects no material impact By Investing.com - Investing.com Canada
Artivion Inc. Discloses November 2024 Cyberattack, Raising Concerns of Possible Data Breach - JD Supra
Artivion's chief accounting officer Amy Horton sells shares for $128,398 - Investing.com
US medical device giant Artivion says hackers stole files during cybersecurity incident - MSN
Medical device company says shipping processes disrupted by ransomware attack - The Record from Recorded Future News
Artivion Inc (AORT) 財務データ
収益
当期純利益
現金流量
EPS
0.47%
大文字化:
|
ボリューム (24 時間):